Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
HPV Vaccination and the Risk of Invasive Cervical CancerThe New England journal of medicine, 2020-10, Vol.383 (14), p.1340-1348 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917338 ;PMID: 32997908Full text available |
|
2 |
Material Type: Article
|
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerThe New England journal of medicine, 2018-11, Vol.379 (20), p.1895-1904 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806395 ;PMID: 30380365Full text available |
|
3 |
Material Type: Article
|
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerThe New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429Full text available |
|
4 |
Material Type: Article
|
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyThe lancet oncology, 2021-04, Vol.22 (4), p.538-547 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30753-1 ;PMID: 33794207Full text available |
|
5 |
Material Type: Article
|
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerThe New England journal of medicine, 2018-11, Vol.379 (20), p.1905-1914 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804923 ;PMID: 30379613Full text available |
|
6 |
Material Type: Article
|
SUCCOR cone study: conization before radical hysterectomyInternational journal of gynecological cancer, 2022-02, Vol.32 (2), p.117-124 [Peer Reviewed Journal]IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002544 ;PMID: 35039455Full text available |
|
7 |
Material Type: Article
|
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505Journal of clinical oncology, 2015-07, Vol.33 (19), p.2129-2135 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.4391 ;PMID: 25732161Full text available |
|
8 |
Material Type: Article
|
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analysesBMJ (Online), 2018-12, Vol.363, p.k4823-k4823 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2018BMJThis is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4823 ;PMID: 30518635Full text available |
|
9 |
Material Type: Article
|
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical CancerInternational journal of gynecological cancer, 2018-05, Vol.28 (4), p.641-655 [Peer Reviewed Journal]2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2018 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1097/IGC.0000000000001216 ;PMID: 29688967Full text available |
|
10 |
Material Type: Article
|
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyThe lancet oncology, 2021-05, Vol.22 (5), p.609-619 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00056-5 ;PMID: 33845034Full text available |
|
11 |
Material Type: Article
|
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023International journal of gynecological cancer, 2023-05, Vol.33 (5), p.649-666 [Peer Reviewed Journal]2023 IGCS and ESGO. This is an open access article under the CC BY license. Published by BMJ. ;2023 2023 IGCS and ESGO. This is an open access article under the CC BY license. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 IGCS and ESGO. This is an open access article under the CC BY license. Published by BMJ. 2023 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004429 ;PMID: 37127326Full text available |
|
12 |
Material Type: Article
|
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysisBJOG : an international journal of obstetrics and gynaecology, 2020-01, Vol.127 (2), p.171 [Peer Reviewed Journal]ISSN: 1471-0528 ;EISSN: 1471-0528 ;DOI: 10.1111/1471-0528.15854Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic reviewThe lancet oncology, 2016-06, Vol.17 (6), p.e240-e253 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30032-8 ;PMID: 27299280 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancerInternational journal of gynecological cancer, 2022-10, Vol.32 (10), p.1236-1243 [Peer Reviewed Journal]IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-003790 ;PMID: 36583728Full text available |
|
15 |
Material Type: Article
|
SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?Annals of surgical oncology, 2023-08, Vol.30 (8), p.4975-4985 [Peer Reviewed Journal]The Author(s) 2023 ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-023-13529-wDigital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Trends in cervical cancer incidence in sub-Saharan AfricaBritish journal of cancer, 2020-07, Vol.123 (1), p.148-154 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0831-9 ;PMID: 32336751Full text available |
|
17 |
Material Type: Article
|
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisThe Lancet infectious diseases, 2015-05, Vol.15 (5), p.565-580 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2015 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(14)71073-4 ;PMID: 25744474 ;CODEN: LANCAOFull text available |
|
18 |
Material Type: Article
|
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21Cancer biology & therapy, 2016-01, Vol.17 (1), p.104-113 [Peer Reviewed Journal]2016 © Taylor & Francis Group, LLC 2016 ;2016 © Taylor & Francis Group, LLC 2016 Taylor & Francis Group, LLC ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2015.1108496 ;PMID: 26574780Full text available |
|
19 |
Material Type: Article
|
Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysisThe lancet oncology, 2017-12, Vol.18 (12), p.1665-1679 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 1, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30700-3 ;PMID: 29126708Full text available |
|
20 |
Material Type: Article
|
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population studyBMJ (Online), 2019-04, Vol.365, p.l1161-l1161 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l1161 ;PMID: 30944092Full text available |